Abstract

The healthcare practice is shaped by practitioners' general perspectives. This study evaluated general opinions on Alzheimer's disease among German various neurological practitioners (AD). Methods: A number of 850 surveys were distributed, with 637 (75%) being returned. Results: For reasons of inadequate compliance in patients with AD, 36% of practitioners said they had not employed medicines for medical diseases other than dementia in these patients. Memory, attention and focus, aggression, depression, activities of daily living, and dependent on carers were all graded on a 5-point scale (very good, good, adequate, sufficient, insufficient) for antidementia medications (donepezil, galantamine, memantine, rivastigmine). In at least two domains, 87 percent of practitioners reported a satisfactory outcome. About 20% of caregivers, according to experts, are treated for psychosocial problems such as depression. Those who practice.